[Therapy of inflammatory rheumatic diseases using cytembena].
D000179:Acrylates / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000840:Anisoles / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001966:Bromine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007659:Ketones / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012595:Scleroderma, Systemic / Q000188:drug therapy; D013167:Spondylitis, Ankylosing / Q000188:drug therapy
D000179:Acrylates; D000840:Anisoles; D000970:Antineoplastic Agents; D007659:Ketones; D001966:Bromine
Lécba zánĕtlivých revmatických chorob cytembenou.